GRFFF yields 7.93% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, GRFFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GRFFF + JNJ for your $10,000?
Fibra Danhos is a Mexican trust established primarily to develop, own, lease, operate and acquire iconic and premier quality commercial real estate assets in Mexico. Our goal is to provide attractive risk-adjusted returns for Holders of our CBFIs in the long term, through stable cash distributions and the appreciation of our properties. We will seek to maintain and grow a portfolio of high-quality properties, through our unmatched development capabilities, and the selective acquisition of iconic and premier-quality properties. We consider a property to be iconic if it has the unique ability to transform the surroundings in which it is located and we consider a property to be of premier quality if it is in prominent locations, it has been developed with the highest standards of construction and design, comprised of high-quality tenants, reports high occupancy rates and, in the case of commercial properties, reports a high volume of visitors.
Full GRFFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.